ESR1 and breast neoplasm: Evaluation of the levels of miR-18a in 275 breast tumour samples by q-PCR showed that miR-18a was highly expressed (p < 0.0001) in the ER-negative tumours (n = 105) when compared to ER-positive tumours (n = 170) (Figure 1A).